Argus•March 03, 2021

CHE: Lowering target price to $463.00

Symbols

Sector(s)

Healthcare

Rating

Current Price

$573.34

Price Target

Earnings Estimate

Summary

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level